Supplemental Fig. 1A. Standard curve of miR-30a-5p using synthetic miRNA.

Slides:

Advertisements

Similar presentations

Figure. S1.1. Absorbance (A 580nm ) of crystal violet destained from Listeria monocytogenes biofilms formed by 18 serotype 1/2a strains and 18 serotype.

Advertisements

Fig. 4-1, p Fig. 4-2, p. 109 Fig. 4-3, p. 110.

Glomerular Diseases Dr. Atapour Differential diagnosis and evaluation of glomerular disease.

Part Three: Etiology & Pathophysiology of Chronic Kidney Disease By T. Parent Nurse Educator, PHC Community Hemodialysis Units 2015.

Case Presentation Dr Mohan Shenoy Consultant Paediatric Nephrologist Royal Manchester Children’s Hospital.

P.464. Table 13-1, p.465 Fig. 13-1, p.466 Fig. 13-2, p.467.

Fig. 11-1, p p. 360 Fig. 11-2, p. 361 Fig. 11-3, p. 361.

Table 6-1, p Fig. 6-1, p. 162 p. 163 Fig. 6-2, p. 164.

Nephritic Syndromes Dr. Raid Jastania.

Hematuria Evaluation of the child with hematuria Causes of hematuria in children.

Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.

This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision of Prof.

Continuity Clinic Proteinuria. Continuity Clinic.

Last class Overall goal for labs 7-9 How to pick candidate miRNA targets Overview: “Validate” target prediction.

Journal Club MicroRNA In Vitro Diagnostics by Use of Immunoassay Analyzers A. Kappel, C. Backes, Y. Huang, S. Zafari, P. Leidinger, B. Meder, H. Schwarz,

1 Alterations of Renal and Urinary Tract Function in Children Chapter 37.

Molecular classification of renal cell carcinoma subtypes using microRNA signatures Zaravinos A 1, Lambrou GI 2, Mourmouras N 3, Delakas D 3, Deltas C.

2006 Renal Week Lecture 3 Hematuria and Glomerulonephritis Debbie Gipson UNC Kidney Cener website: password:

A convenient system for highly specific and sensitive detection of miRNA expression Xiangqi Li, Minjie Ni, Chaobao Zhang, Wubin Ma, Yonglian Zhang SUPPLEMENTAL.

Ａ 45 year old man Presented with hematuria from 3 months ago No Dysuria or Frequency No pain Physical examination is normal.

MicroRNA implication in urinary bladder cancer A. Zaravinos 1, J. Radojicic 3, G.I. Lambrou 2, D. Volanis 1,4, D. Delakas 4, E.N. Stathopoulos 3, D.A.

Supplemental Data Fig. 1A. Standard curves of miR-34c-5p using synthetic miRNAs.

Apostolos Zaravinos and Constantinos C Deltas Molecular Medicine Research Center and Laboratory of Molecular and Medical Genetics, Department of Biological.

NYU Medical Grand Rounds Clinical Vignette Matko Kalac, MD PGY-2 9/18/2012 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.

Glomerulonephritis Brian S. Pavey, DO, MS. Presentation Sudden onset – Hematuria – Hypertension – Edema – Acute kidney injury.

Last class Plasmid isolation from bacteria Paper 2: miRNAs in iPSCs.

MiR-21 can be used as independent prognostic factor for survival and metastasis in urinary bladder cancer. Apostolos Zaravinos 1, Jelena Radojicic 3, George.

Partial recovery Lost sample 1,000 fmols 0.1 fmols 1.0 fmols Neg. control Supplemental Fig. 1. Quality control for extraction procedures using spiked-in.

Supplemental Table 1. Oligonucleotide sequences used for mRNA expression analysis by qPCR. Primer name Forward Primer 5’- 3’Reverse Primer 5’-3’ KLK3 5’-GTGCTTGTGGCCTCTCG-3’

Figure S UV- UV+ Relative expression levels of rhoB mRNA by qRT-PCR *

Elsevier items and derived items © 2008 by Mosby, Inc., an affiliate of Elsevier Inc. Some material was previously published. Alterations of Renal and.

KIDNEY LECTURES DayTimeQuarter 5LecturerSubject Tue 10:00 a-11:00 a12/1/2015Lu, YuxinKidney I - Glomerular Disease Tue 11:00 a-12:00 p12/1/2015Lu,

Expression profile of oncomiRs and tumor-suppressor miRs in urothelial carcinoma of the bladder Apostolos Zaravinos 1, George I. Lambrou 2, Jelena Radojicic.

Growth factor PI3K PDK1/2 PIP 3 AKT CASP9 FOXO1 BAD CDKN1A CDKN1B MDM2 GSK3B CHUK mTOR PTEN miR-26ab/1297; miR-148/152; miR-103/107; miR-19; miR-425/489;

1 HENOCH–SCHONLEIN PURPURA M. Sjabaroeddin Loebis, Lily Irsa, Rita Evalina Allergy Immunology Division Pediatrics Departement Medical Faculty Sumatera.

Recurrence of Henoch-Schonlein purpura nephritis after 6.5 years of remission- an unusual clinical occurrence Vignesh Pandiarajan*, Deepti Suri*, Anju.

사구체신염 진단 Tips 신장내과 임천규. Chang JH et al, Nephrol Dial Transplant 2009 Changing prevalence of glomerular diseases in Korean adults IgAN MN MCD FSGS MPGN.

Last class Overall goal for labs 7-9 How to pick candidate miRNA targets Overview: “Validate” target prediction.

Author(reference) down up Supplemental data S1. differentially expressed miRNAs in selected microarray studies Murakami (14)miR-18, miR-224miR-199a, miR-195,

Characterization of Serum MicroRNAs Profile of PCOS and Identification of Novel Non-Invasive Biomarkers Cell Physiol Biochem 2014;33: DOI: /

Am J Nephrol 2013;38: DOI: / Fig. 1. Study selection process.

WP2 – ddPCR and microRNA C.Divieto, INRIM, Torino, Italy.

The Clinical Significance of Uric Acid and Complement Activation in the Progression of IgA Nephropathy Kidney Blood Press Res 2016;41: DOI: /

Fig. 1. The distribution of serum anti-dust EV IgG concentrations in the healthy control, asthma, COPD, and lung cancer groups. The dashed vertical line.

Supplemental File 2 A B Supplemental File 2: Cell counting assay

Supplemental table 3 miRNA shoot Root + - miRC

Cell Physiol Biochem 2016;40: DOI: /

Jean-Claude Davin, Ineke J. Ten Berge, Jan J. Weening

Improvement of idiopathic membranous nephropathy diagnosis with ultrasensitive quantitative detection of anti-phospholipase A2 receptor Biao Huang, PhD,

Validation of Circulating miRNA Biomarkers for Predicting Lymph Node Metastasis in Gastric Cancer Shine Young Kim, Tae Yong Jeon, Chang In Choi, Dae.

LNCaP * C4-2B Du145 22Rv1 SI Figure 1. miR-124 inhibits the proliferation of CaP cells. WST-1 cell proliferation analysis of AR-positive CaP cell lines.

Tyrosinase-Based Reporter Gene for Photoacoustic Imaging of MicroRNA-9 Regulated by DNA Methylation in Living Subjects Haifeng Zheng, Lin Zhou, Yaru.

Kimberley Bexon, Graham Williams

MicroRNAs: Hidden in the Genome

Molecular Therapy - Nucleic Acids

Concentrations of (A) faecal IgA (µg IgA/µg TP), (B) serum IgA (g/l) and (c) serum IgE (g/l) in puppies at 7 weeks, 12–13 months and 15–18 months of age.

Suaad Alshehhi, Nicola A. McCallum, Penelope R. Haddrill

Quantification of Circulating miRNAs in Plasma

Joanna K. Boyd, Jonathan Barratt Kidney International

Volume 80, Issue 1, Pages (July 2011)

Find d y/d x x = 6t e t , y = 6t + e t

Fig. 6. CXM correlates with age and growth velocity.

Casein-related anaphylaxis after use of an Everlast kickboxing glove

Fig. 2. Cellular response to FolamiRs in vitro.

Molecular and immunohistochemical detection of rotavirus in urinary sediment cells of children with rotavirus gastroenteritis T. Yokoyama, N. Sugimoto,

C1q Nephropathy American Journal of Kidney Diseases

Differential expression of microRNAs in exhaled breath condensates of patients with asthma, patients with chronic obstructive pulmonary disease, and healthy.

Supplemental Fig 1 (A) (B) (B) 59% % alive 52% Years from entry 59%

Fig. 2. Effects of calcium supplements on serum total calcium concentration in normal postmenopausal women. (A) The calcaemic effects of calcium (500 mg)

Fig. 2. Cellular response to FolamiRs in vitro.

Presentation transcript:

Supplemental Fig. 1A. Standard curve of miR-30a-5p using synthetic miRNA.

Supplemental Fig. 1B. Standard curve of miR-151-3p using synthetic miRNA.

Supplemental Fig. 1C. Standard curve of miR-150 using synthetic miRNA.

Supplemental Fig. 1D. Standard curve of miR-191 using synthetic miRNA.

Supplemental Fig. 1E. Standard curve of miR-19b using synthetic miRNA.

Supplemental Fig. 2. The repeatability of urinary RNA extraction for the analytical characterization of hydrolysis probe-based RT-qPCR assay.

Supplemental Fig. 3. The serum concentrations of the selected 5 miRNAs in children with other kidney diseases. HSPN, Henoch-Schönlein purpura nephropathy, n = 18; Ig AN, IgA nephropathy, n = 15; LN, lupus nephritis, n = 11; NC, normal controls, n = 16.